Antiretroviral therapy (ART) treated HIV is associated with an inflammatory profile and increased risk of cardiovascular disease (CVD). Monocytes that home to endothelium and differentiate into macrophages in the vessel wall may contribute to CVD risk in people with HIV (PWH). We reported that statins reduce inflammation in PWH. We hypothesized that rosuvastatin would improve the lipidomes of PWH and reduce the proinflammatory signatures in macrophages.
SATURN-HIV, a placebo-controlled trial [NCT01218802], assessed the effects of rosuvastatin (10 mg) on immune activation in ART-treated PWH. Here, we measured the lipidomes (Lipidyzer platform) of participants at baseline (BL) and at 48 weeks (WK48) of statin or placebo treatment (N=14/group). Participants were demographically similar (placebo:mean 39 years of age, 79% male, 57% African American, AA; statin:43 years, 93% male, 71% AA). Pooled serum samples from statin or placebo-treated individuals at BL or WK48 were added to PBMCs from HIV- donors (N=7) to generate monocyte derived macrophages (MDM). MDM RNA was extracted and sequenced via Illumina TruSeq Stranded Total RNA library kits and NovaSeq system. Using R Bioconductor, we performed differential gene expression (DGE) analysis (LIMMA) and pathway analyses (GSVA). Regression analysis between DEGs and lipids identified genes and pathways that are regulated with lipid changes.
Statins reduced several lipid classes and species, including levels of ceramides (CER), and lipids linked to CVD in PWH (CER16:0, 22:0, 24:0, 24:1, p<0.04). DGE analysis of MDMs from statin vs placebo paired double contrast revealed a decrease in interleukin signaling, reactive oxygen species, and complement pathways in the statin group. Scavenger and lipid receptors, MSR1 and OLR1, were increased with statins, while chemokine, integrin and JAK-STAT kinase DGE decreased. We compared our top DEGs (p?0.05) to those from our previous MDM PWH vs HIV- analysis and identified genes that are inversely regulated by statin use. INHBA (p=0.005), CD300E (p=0.0006), and IL1B (p=0.03) were downregulated with statins and upregulated in MDMs from PWH vs HIV- subjects. LDHD, a gene related to lipid processing, was upregulated in the statin group (p=0.039) and decreased in PWH vs HIV- subjects.
Rosuvastatin in ART-treated PWH may lead to a reduced inflammatory response and CVD risk by downregulating pro-atherosclerotic and immune activation signaling in MDMs. *MJC and NTF equal contribution.